Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-28

Clinical Trial Update: Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss After Total Hip Replacement [Phase 2]

View source ↗

Summary

Phase 2 trial comparing oral tranexamic acid to oral aminocaproic acid for reducing blood loss after total hip replacement has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aminocaproic acid (oral) (aminocaproic acid)
  • Tranexamic acid (oral) (tranexamic acid)

Snippet

Sponsor: Carlos A Acosta-Olivo | Conditions: Blood Loss, Surgical | Phase 2 | Status: COMPLETED